Cyient DLM Ltd Q1 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/xnpgv3oj4i2shcu8kmsymiik.pdf

Key Takeaways


Working Capital & Balance Sheet


Revenue Mix & End-Market Demand

Anthony Montalbano: "it really comes down to the type of work we do and the sectors and types of clients we do it. So it's really mission critical, safety critical, electronics manufacturing services primarily focused on aero and defense, medical and industrial segments."

Order Book & Pipeline


Margin Structure & Expansion Path

Anthony Montalbano: "So, where we are today as we continue to scale and absorb the costs and along with some operational efficiencies that alone can give us one, two points of opportunity from an EBIDTA perspective and another area of margin expansion for us is really on these build-to-spec program where we do the design and manufacturing... that can give us maybe another point-to-point and a half opportunity there on the overall business."

Business Model & Competitive Positioning


Capital Allocation & Returns

Management: "As we have done with Cyient in the past, we will plan to also host an investor day for Cyient DLM Investors show. So, we can actually showcase, and as you know in this case there's a lot more to showcase, our manufacturing facilities and capabilities, and we will keep you posted on that."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthHigher than industry average for the yearFY24
EBITDA marginSimilar to last year, 10–11%FY24
Gross marginFull-year range similar to Q1FY24
DIO reduction~140 days by end of Q2, ~120 days by year-endQ2 FY24 / FY24 exit
Net working capital~60 days by year-endFY24 exit
PATSignificant increase for rest of year, aided by lower finance charges and higher other incomeFY24
Order book conversionMore than 50% of ₹2,500 crore order book executableNext 12 months
ROCE20–25% rangeOver a couple of years
H1/H2 seasonalityH1 ~45%, H2 ~55% of full-year revenueFY24

Key Metrics

MetricQ1 FY24
Revenue₹217.1 cr, +27.6% YoY
EBITDA₹20 cr, +72.6% YoY
EBITDA margin9.2%, up 243 bps YoY
PAT126 bps lower YoY, due to higher finance charges and absence of one-off forex gains in base quarter
Gross marginSignificantly higher YoY, driven by better revenue mix and one-offs in Q1 last year
Order backlog₹2,499.7 cr, +89% YoY
Order intake during quarter₹3.36 cr
Revenue mix: Aerospace & Defense56% of revenue
Revenue mix: Industrial30% of revenue
Revenue mix: Med-tech10% of revenue
Revenue mix: Others (primarily rail)4% of revenue
Export share~70% of revenue, domestic 30%
DIO (inventory days)187 days, expected to reduce to 140 days by Q2 and 120 days by year-end
DSO (receivables days)~90 days, elevated due to collections received post quarter-end
Net working capital days98 days, target of 60 days by year-end
PipelineOver ₹70 cr, backed by major aerospace and defense clients
ROCE target20% to 25%, expected to take a couple of years to achieve